Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.6.

  • Anika Therapeutics' Asset Utilization Ratio rose 7103.68% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 7103.68%. This contributed to the annual value of 0.51 for FY2024, which is 2996.53% up from last year.
  • According to the latest figures from Q3 2025, Anika Therapeutics' Asset Utilization Ratio is 0.6, which was up 7103.68% from 0.61 recorded in Q2 2025.
  • Anika Therapeutics' 5-year Asset Utilization Ratio high stood at 0.61 for Q2 2025, and its period low was 0.33 during Q4 2022.
  • Over the past 5 years, Anika Therapeutics' median Asset Utilization Ratio value was 0.4 (recorded in 2021), while the average stood at 0.43.
  • As far as peak fluctuations go, Anika Therapeutics' Asset Utilization Ratio tumbled by 2321.93% in 2023, and later skyrocketed by 7103.68% in 2025.
  • Over the past 5 years, Anika Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.42 in 2021, then fell by 22.59% to 0.33 in 2022, then grew by 23.5% to 0.4 in 2023, then skyrocketed by 36.91% to 0.55 in 2024, then grew by 8.3% to 0.6 in 2025.
  • Its Asset Utilization Ratio stands at 0.6 for Q3 2025, versus 0.61 for Q2 2025 and 0.6 for Q1 2025.